Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yung-Chieh Tseng

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Applied Optics|October 20, 2015
Color multiplexing method to capture front and side images with a capsule endoscopeYung-Chieh Tseng, Hsun-Ching Hsu, Pin Han, et al.
Journal of Biomedical Science|February 16, 2020
Better influenza vaccines: an industry perspectiveJuine-Ruey Chen, Yo-Min Liu, Yung-Chieh Tseng, et al.
Vaccine|April 6, 2024
Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccineChia-Ying Wu, Shao-En Kao, Yung-Chieh Tseng, et al.
Antiviral Research|November 20, 2023
Monoglycosylated SARS-CoV-2 receptor binding domain fused with HA<sub>stem</sub>-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza virusesChia-Ying Wu, Yung-Chieh Tseng, Shao-En Kao, et al.
Vaccines|June 27, 2024
An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus InfectionShiou-Chih Hsu, Kun-Hsien Lin, Yung-Chieh Tseng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2019
Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infectionsYung-Chieh Tseng, Chia-Yu Wu, Ming-Liang Liu, et al.
Antiviral Research|June 1, 2023
Pilot-scale production of inactivated monoglycosylated split H<sub>1</sub>N<sub>1</sub> influenza virus vaccine provides cross-strain protection against influenza virusesChia-Ying Wu, Shao-En Kao, Yung-Chieh Tseng, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infectionsJuine-Ruey Chen, Yueh-Hsiang Yu, Yung-Chieh Tseng, et al.
Plos Pathogens|August 5, 2021
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cellsYi-An Ko, Yueh-Hsiang Yu, Yen-Fei Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2009
Glycans on influenza hemagglutinin affect receptor binding and immune responseCheng-Chi Wang, Juine-Ruey Chen, Yung-Chieh Tseng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Applied Optics|October 20, 2015
Color multiplexing method to capture front and side images with a capsule endoscopeYung-Chieh Tseng, Hsun-Ching Hsu, Pin Han, et al.
Journal of Biomedical Science|February 16, 2020
Better influenza vaccines: an industry perspectiveJuine-Ruey Chen, Yo-Min Liu, Yung-Chieh Tseng, et al.
Vaccine|April 6, 2024
Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccineChia-Ying Wu, Shao-En Kao, Yung-Chieh Tseng, et al.
Antiviral Research|November 20, 2023
Monoglycosylated SARS-CoV-2 receptor binding domain fused with HA<sub>stem</sub>-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza virusesChia-Ying Wu, Yung-Chieh Tseng, Shao-En Kao, et al.
Vaccines|June 27, 2024
An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus InfectionShiou-Chih Hsu, Kun-Hsien Lin, Yung-Chieh Tseng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2019
Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infectionsYung-Chieh Tseng, Chia-Yu Wu, Ming-Liang Liu, et al.
Antiviral Research|June 1, 2023
Pilot-scale production of inactivated monoglycosylated split H<sub>1</sub>N<sub>1</sub> influenza virus vaccine provides cross-strain protection against influenza virusesChia-Ying Wu, Shao-En Kao, Yung-Chieh Tseng, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infectionsJuine-Ruey Chen, Yueh-Hsiang Yu, Yung-Chieh Tseng, et al.
Plos Pathogens|August 5, 2021
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cellsYi-An Ko, Yueh-Hsiang Yu, Yen-Fei Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2009
Glycans on influenza hemagglutinin affect receptor binding and immune responseCheng-Chi Wang, Juine-Ruey Chen, Yung-Chieh Tseng, et al.
Pageof 2